Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

 News

Dr Ignatiadis

Personalization of treatment of HER2+ breast cancer

Press release (28/05/2018) A patient’s immune response makes it possible to personalize treatment of HER2 positive breast cancer. Brussels, 28 of May 2018 - Researchers at the Jules Bordet Institute published last week, in the Journal of the National Cancer Institute, a study permitting the advance identification, among women suffering from an HER2-positive breast cancer, of those who will and will not respond positively to…
(read more)

101 Tables pour la vie

05/06/2018 14th edition  of the "101 Tables pour la Vie" L'Arsenal (next to the Delvaux workshops) Gastronomic evening benefiting the research laboratories of the new Institut Bordet

Ghislaine Arabian, Pascal Devalkeneer and Yves Mattagne will cook in front of you! Information: 02/541 34 14   Website : http://www.amis-bordet.be/amis-institut-bordet-accueil.html
(read more)

Oncodistinct team

Oncodistinct, a multidisciplinary clinical research network

Press release (23/05/2018) Oncodistinct, a multidisciplinary clinical research network that meets patients' needs Brussels, 23 May 2018 – Cancer research is advancing by leaps and bounds with fast changing developments in cancer treatment. To respond to these changes, clinical research in cancerology must also change. Today there is a real need for new structures that facilitate the pooling of expertise and resources…
(read more)

Drs Pondé, de Azambuja, Lambertini

The new generation of researchers doubly rewarded

Press release (15/05/2018) The new generation of researchers doubly rewarded.
Double Merit Award of the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) 2018 in the field of breast cancer for two young researchers at the Institut Jules Bordet Brussels, 16th May 2018 – On 15 May 2018, Noam Pondé and Matteo Lambertini, researchers at the Institut Jules Bordet, both received a Merit Award from the Conquer Cancer…
(read more)

Christine Desmedt

Lambertine-Lacroix Prize - Cancerology 2018: Ch Desmedt

Press release (09/05/2018) 2018 Lambertine-Lacroix Prize - Cancerology awarded to the researcher Christine Desmedt of the Jules Bordet Institute, Université Libre de Bruxelles 9 May 2018 – Christine Desmedt, researcher at the Jules Bordet Institute, was awarded this Tuesday 8 May the Lambertine-Lacroix Prize from the National Fund for Scientific Research (FNRS) for her extensive research into our understanding of…
(read more)

melanoom

Tips to avoid melanoma now that spring has sprung

Press release (07/05/2018) We're full of the joys of spring. But be careful what it might bring!
Here are a few tips to avoid melanoma now that spring has sprung. Brussels, 7th May 2018 – The first rays of sunshine have already made their appearance in Belgium these past weeks. It's perfect weather for showing off one's legs and shoulders, but in moderation, and above all with protection! It's also the opportunity for Institut Jules Bordet…
(read more)

Reduction of the risk of breast cancer recurrence

Press release (03/05/2018) The administration of an anti-inflammatory drug during the ablation of the primary tumour reduces the risk of breast cancer recurrence in overweight or obese patients 3 of May 2018 - Christine Desmedt, researcher at the Jules Bordet Institute, on collaboration with the VUB, the UCL and Elia Biganzoli at Istituto Nazionale dei Tumori and University of Milan, published on 30 April in "The Journal of the…
(read more)

Patrick Miqueu

Whether or not to participate in a clinical trial 

The Jules Bordet Institute is developing an innovative digital tool to support patients in their decision-making. To develop, with the assistance of patients, a digital tool that enables patients to decide in full knowledge of the facts whether or not to take part in a clinical trial. Such is the project pursued by Patrick Miqueu at the Jules Bordet Institute. An ambitious project of crucial importance to patients that aims to ensure they are…
(read more)

Le CHU Bruxelles, acteur hospitalier d’envergure dans l’économie bruxelloise

Le CHU Bruxelles, acteur hospitalier d’envergure dans l’économie bruxelloise:  1 milliard de retombées économiques et près de 7.800 emplois générés à Bruxelles en 2016. Le Centre Hospitalier Universitaire de Bruxelles (CHU Bruxelles) et la Chambre de Commerce et de l’Industrie et Union des Entreprises de Bruxelles (BECI) se sont associés pour étudier les retombées économiques et sociétales des hôpitaux de la Ville de Bruxelles, réunis…
(read more)

Martine Piccart

Portrait of Pr Martine Piccart, award-winner of the Prix Fondation ARC Léopold Griffuel for translational and clinical research

On Thursday April 5th, the Professor Martine Piccart received the 46th Prix Fondation ARC Léopold Griffuel for translationnal and clinical research. This prestigious prize rewards annually researchers of international rewnown whose work has resulted in a major advance in cancer research. Wonderful recognition for the research work she has pursued for more than 20 years in the field of breast cancer research. Discover or rediscover her…
(read more)